FindTrial
Sign In

Effect of traditional ayurvedic formulation vs yoga vs conventional treatment in patients with Hypothyroidism.

Randomized, Open-Labelled, Parallel Group, Three-Arm Clinical Trial on Effect of Ayurvedic Drug Formulation (Thyrogrit) Vs. Yogic Practices Vs. Conventional Drug (Levothyroxine) in Patients with Hypothyroidism.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038780
Enrollment
93
Registered
2021-12-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E038- Other specified hypothyroidism

Interventions

None listed

Sponsors

Patanjali Research Institute governed by Patanjali Research Foundation Trust
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed with Subclinical hypothyroidism. Patients willing to participate in the study and ready to provide informed consent.

Exclusion criteria

Exclusion criteria: Patients diagnosed with type of hypothyroidism other than Subclinical hypothyroidism. Patients with age below 30 years and above 65 years. Pregnant females. Patients underwent recent thyroid surgery. Patients used hormonal contraceptives in recent history of three months. Alcohol and smoking addicted patients. Patients hypersensitive to study medication and its composition. Patients unwillingness or inability to follow the procedure outlined in protocol. Patients who are mentally or legally incapable of understanding informed consent form. Patients with slip disc, cervical spondylitis, severe back problems, recent surgical history are excluded in yogic intervention.

Design outcomes

Primary

MeasureTime frame
Changes in clinical markers of thyroid function (TSH, T4, T3). Effects of Thyrogrit ayurvedic medicine, in patients with hypothyroidism, in comparison of conventional drug. Effects of yogic practices, in patients with hypothyroidism, in comparison of conventional drug.Timepoint: Difference in clinical markers of thyroid from baseline to day 60.—

Secondary

MeasureTime frame
Change in Quality of life measured with The Quality of Life (THYROID VERSION) among patients. Change in physical activities with International Physical Activity Questionnaire (Short Form) among patients. Change in five dimensions of fatigue with the help of Multidimensional Fatigue Inventory (MFI). Change in obesity measured with Body Mass Index (BMI). Change in effect of intervention on psychological well-being with Depression, Anxiety, and Stress Scale 21.Timepoint: Difference in thyroid related quality of life, physical activities, fatigue, body mass index and psychological well being of subclinical hypothyroid patients from baseline to day 60.—

Countries

India

Contacts

Public ContactGarima

Patanjali Yog Gram

principal.investigator@prft.in7302254793

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026